{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:54:40Z","timestamp":1783040080706,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12033-023-00872-2","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T10:01:57Z","timestamp":1695463317000},"page":"2441-2454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel"],"prefix":"10.1007","volume":"66","author":[{"given":"Negin","family":"Riazi-Tabrizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khalaj-Kondori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Safaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Maghsoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-6795","authenticated-orcid":false,"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"issue":"6","key":"872_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians, 68(6), 394\u2013424.","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"35","key":"872_CR2","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.3748\/wjg.v27.i35.5851","volume":"27","author":"V Tonini","year":"2021","unstructured":"Tonini, V., & Zanni, M. (2021). Pancreatic cancer in 2021: What you need to know to win. World Journal of Gastroenterology, 27(35), 5851.","journal-title":"World Journal of Gastroenterology"},{"issue":"27","key":"872_CR3","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","volume":"27","author":"J-X Hu","year":"2021","unstructured":"Hu, J.-X., et al. (2021). Pancreatic cancer: A review of epidemiology, trend, and risk factors. World Journal of Gastroenterology, 27(27), 4298.","journal-title":"World Journal of Gastroenterology"},{"issue":"14","key":"872_CR4","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.7314\/APJCP.2015.16.14.5619","volume":"16","author":"V Goral","year":"2015","unstructured":"Goral, V. (2015). Pancreatic cancer: Pathogenesis and diagnosis. Asian Pacific Journal of Cancer Prevention, 16(14), 5619\u20135624.","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"872_CR5","unstructured":"Darmawan, G. & Simadibrata, M. (2011). Pancreatic cancer: Review of etiology, clinical features, diagnostic procedures, treatment and mesothelin role. Indonesian Association for the Study of the Liver."},{"key":"872_CR6","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3389\/fonc.2020.01492","volume":"10","author":"S Dai","year":"2020","unstructured":"Dai, S., Mo, Y., Wang, Y., Xiang, B., Liao, Q., Zhou, M., Li, X., Li, Y., Xiong, W., Li, G., Guo, C., & Zeng, Z. (2020). Chronic stress promotes cancer development. Frontiers in Oncology, 10, 1492.","journal-title":"Frontiers in Oncology"},{"key":"872_CR7","unstructured":"Teymouri, A., Mohammadi\u2010Yeganeh, S., Bayat, S., Rezaee, D., Ghavidel, A. A., & Ghanbarian, H. (2020). Non-viral siRNA delivery systems for pancreatic cancer therapy. Authorea Preprints."},{"issue":"2","key":"872_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/21691401.2017.1307210","volume":"46","author":"A Singh","year":"2018","unstructured":"Singh, A., Trivedi, P., & Jain, N. K. (2018). Advances in siRNA delivery in cancer therapy. Artificial Cells, Nanomedicine, and Biotechnology, 46(2), 274\u2013283.","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"872_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.redox.2015.06.014","volume":"5","author":"G Manda","year":"2015","unstructured":"Manda, G., Isvoranu, G., Comanescu, M. V., Manea, A., Butuner, B. D., & Korkmaz, K. S. (2015). The redox biology network in cancer pathophysiology and therapeutics. Redox Biology, 5, 347\u2013357.","journal-title":"Redox Biology"},{"issue":"21","key":"872_CR10","doi-asserted-by":"publisher","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","volume":"91","author":"P Moi","year":"1994","unstructured":"Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region. Proceedings of the National Academy of Sciences USA, 91(21), 9926\u20139930.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"6","key":"872_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1039\/C9NP00061E","volume":"37","author":"DD Zhang","year":"2020","unstructured":"Zhang, D. D., & Chapman, E. (2020). The role of natural products in revealing NRF2 function. Natural Product Reports, 37(6), 797\u2013826.","journal-title":"Natural Product Reports"},{"issue":"16","key":"872_CR12","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","volume":"24","author":"A Kobayashi","year":"2004","unstructured":"Kobayashi, A., Kang, M. I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Molecular and Cellular Biology, 24(16), 7130\u20137139.","journal-title":"Molecular and Cellular Biology"},{"issue":"1","key":"872_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1101\/gad.13.1.76","volume":"13","author":"K Itoh","year":"1999","unstructured":"Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes & Development, 13(1), 76\u201386.","journal-title":"Genes & Development"},{"issue":"2","key":"872_CR14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1096\/fj.12-217257","volume":"27","author":"P Shelton","year":"2013","unstructured":"Shelton, P., & Jaiswal, A. K. (2013). The transcription factor NF-E2-related factor 2 (Nrf2): A protooncogene? The FASEB Journal, 27(2), 414\u2013423.","journal-title":"The FASEB Journal"},{"issue":"1","key":"872_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-10-37","volume":"10","author":"A Lister","year":"2011","unstructured":"Lister, A., Nedjadi, T., Kitteringham, N. R., Campbell, F., Costello, E., Lloyd, B., Copple, I. M., Williams, S., Owen, A., Neoptolemos, J. P., Goldring, C. E., & Park, B. K. (2011). Nrf2 is overexpressed in pancreatic cancer: Implications for cell proliferation and therapy. Molecular Cancer, 10(1), 1\u201313.","journal-title":"Molecular Cancer"},{"issue":"4","key":"872_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2016.06.056","volume":"166","author":"IIC Chio","year":"2016","unstructured":"Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., \u00d6hlund, D., Wright, K., Filippini, D., Lee, E. J., Da Silva, B., Schoepfer, C., Wilkinson, J. E., Buscaglia, J. M., DeNicola, G. M., Tiriac, H., \u2026 Tuveson, D. A. (2016). NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell, 166(4), 963\u2013976.","journal-title":"Cell"},{"key":"872_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3687700","author":"J Sharifi-Rad","year":"2021","unstructured":"Sharifi-Rad, J., Quispe, C., Patra, J. K., Singh, Y. D., Panda, M. K., Das, G., Adetunji, C. O., Michael, O. S., Sytar, O., Polito, L., \u017divkovi\u0107, J., Cruz-Martins, N., Klimek-Szczykutowicz, M., Ekiert, H., Choudhary, M. I., Ayatollahi, S. A., Tynybekov, B., Kobarfard, F., Muntean, A. C., \u2026 Calina, D. (2021). Paclitaxel: Application in modern oncology and nanomedicine-based cancer therapy. Oxidative Medicine and Cellular Longevity. https:\/\/doi.org\/10.1155\/2021\/3687700","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"3","key":"872_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000334704","volume":"4","author":"H Igarashi","year":"2011","unstructured":"Igarashi, H., Ito, T., Hisano, T., Fujimori, N., Niina, Y., Yasuda, M., Kaku, T., Matsuo, S., Oono, T., Yoshinaga, M., Sakai, H., & Takayanagi, R. (2011). Paclitaxel-based chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy failure: A case series of 5 patients. Case Reports in Oncology, 4(3), 534\u2013541.","journal-title":"Case Reports in Oncology"},{"key":"872_CR19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/annonc\/5.suppl_4.S3","volume":"5","author":"S Horwitz","year":"1994","unstructured":"Horwitz, S. (1994). Taxol (paclitaxel): Mechanisms of action. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 5, S3-6.","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"issue":"4","key":"872_CR20","first-page":"271","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016). Cancer treatment and survivorship statistics. CA: A Cancer Journal for Clinicians, 66(4), 271\u2013289.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"872_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.20517\/2394-4722.2018.13","volume":"4","author":"NP Pereira","year":"2018","unstructured":"Pereira, N. P., & Corr\u00eaa, J. R. (2018). Pancreatic cancer: Treatment approaches and trends. Journal of Cancer Metastasis and Treatment, 4, 30.","journal-title":"Journal of Cancer Metastasis and Treatment"},{"issue":"17","key":"872_CR22","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMra0901557","volume":"362","author":"M Hidalgo","year":"2010","unstructured":"Hidalgo, M. (2010). Pancreatic cancer. New England Journal of Medicine, 362(17), 1605\u20131617.","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"872_CR23","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/cancers11111755","volume":"11","author":"AA Zimta","year":"2019","unstructured":"Zimta, A. A., Cenariu, D., Irimie, A., Magdo, L., Nabavi, S. M., Atanasov, A. G., & Berindan-Neagoe, I. (2019). The role of Nrf2 activity in cancer development and progression. Cancers, 11(11), 1755.","journal-title":"Cancers"},{"issue":"10","key":"872_CR24","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1158\/1078-0432.CCR-04-2159","volume":"11","author":"PO Berberat","year":"2005","unstructured":"Berberat, P. O., Dambrauskas, Z., Gulbinas, A., Giese, T., Giese, N., K\u00fcnzli, B., Autschbach, F., Meuer, S., B\u00fcchler, M. W., & Friess, H. (2005). Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clinical Cancer Research, 11(10), 3790\u20133798.","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"872_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4174\/astr.2020.98.4.159","volume":"98","author":"YJ Lee","year":"2020","unstructured":"Lee, Y. J., Kim, W. I., Bae, J. H., Cho, M. K., Lee, S. H., Nam, H. S., Choi, I. H., & Cho, S. W. (2020). Overexpression of Nrf2 promotes colon cancer progression via ERK and AKT signaling pathways. Annals of Surgical Treatment and Research, 98(4), 159.","journal-title":"Annals of Surgical Treatment and Research"},{"issue":"1","key":"872_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1541-1","volume":"15","author":"M Zhang","year":"2015","unstructured":"Zhang, M., Zhang, C., Zhang, L., Yang, Q., Zhou, S., Wen, Q., & Wang, J. (2015). Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma. BMC Cancer, 15(1), 1\u201312.","journal-title":"BMC Cancer"},{"issue":"8","key":"872_CR27","doi-asserted-by":"publisher","first-page":"e0133876","DOI":"10.1371\/journal.pone.0133876","volume":"10","author":"JQ Ma","year":"2015","unstructured":"Ma, J. Q., Tuersun, H., Jiao, S. J., Zheng, J. H., Xiao, J. B., & Hasim, A. (2015). Functional role of NRF2 in cervical carcinogenesis. PLoS ONE, 10(8), e0133876.","journal-title":"PLoS ONE"},{"issue":"1","key":"872_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12154-015-0144-2","volume":"9","author":"MA Esmaeili","year":"2016","unstructured":"Esmaeili, M. A. (2016). Combination of siRNA-directed gene silencing with epigallocatechin-3-gallate (EGCG) reverses drug resistance in human breast cancer cells. Journal of Chemical Biology, 9(1), 41\u201352.","journal-title":"Journal of Chemical Biology"},{"issue":"1","key":"872_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1179\/1743132812Y.0000000094","volume":"35","author":"H Pan","year":"2013","unstructured":"Pan, H., Wang, H., Zhu, L., Wang, X., Cong, Z., Sun, K., & Fan, Y. (2013). The involvement of Nrf2\u2013ARE pathway in regulation of apoptosis in human glioblastoma cell U251. Neurological Research, 35(1), 71\u201378.","journal-title":"Neurological Research"},{"issue":"5","key":"872_CR30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.14348\/molcells.2015.2268","volume":"38","author":"Y-J Lee","year":"2015","unstructured":"Lee, Y.-J., Lee, D. M., & Lee, S.-H. (2015). Nrf2 expression and apoptosis in quercetin-treated malignant mesothelioma cells. Molecules and Cells, 38(5), 416.","journal-title":"Molecules and Cells"},{"issue":"5","key":"872_CR31","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/antiox11050946","volume":"11","author":"D Lastra","year":"2022","unstructured":"Lastra, D., Escoll, M., & Cuadrado, A. (2022). Transcription factor NRF2 participates in cell cycle progression at the level of G1\/S and mitotic checkpoints. Antioxidants, 11(5), 946.","journal-title":"Antioxidants"},{"issue":"6","key":"872_CR32","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3892\/or.2012.2060","volume":"28","author":"YH Choi","year":"2012","unstructured":"Choi, Y. H., & Yoo, Y. H. (2012). Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1\/CIP1, in human breast cancer cells. Oncology Reports, 28(6), 2163\u20132169.","journal-title":"Oncology Reports"},{"issue":"10","key":"872_CR33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.7150\/ijbs.26776","volume":"14","author":"X Li","year":"2018","unstructured":"Li, X., Liang, M., Jiang, J., He, R., Wang, M., Guo, X., Shen, M., & Qin, R. (2018). Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production and ER stress in pancreatic cancer cells. International Journal of Biological Sciences, 14(10), 1291.","journal-title":"International Journal of Biological Sciences"},{"key":"872_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3897250","author":"L Zhang","year":"2016","unstructured":"Zhang, L., Li, J., Ma, J., Chen, X., Chen, K., Jiang, Z., Zong, L., Yu, S., Li, X., Xu, Q., Lei, J., Duan, W., Li, W., Shan, T., Ma, Q., & Shen, X. (2016). The relevance of Nrf2 pathway and autophagy in pancreatic cancer cells upon stimulation of reactive oxygen species. Oxidative Medicine and Cellular Longevity. https:\/\/doi.org\/10.1155\/2016\/3897250","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"5","key":"872_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.11959","volume":"23","author":"J Liu","year":"2021","unstructured":"Liu, J., Qin, X., Ma, W., Jia, S., Zhang, X., Yang, X., Pan, D., & Jin, F. (2021). Corilagin induces apoptosis and autophagy in NRF2-addicted U251 glioma cell line. Molecular Medicine Reports, 23(5), 1\u201310.","journal-title":"Molecular Medicine Reports"},{"issue":"45","key":"872_CR36","doi-asserted-by":"publisher","first-page":"73593","DOI":"10.18632\/oncotarget.12435","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang, C., Wang, H. J., Bao, Q. C., Wang, L., Guo, T. K., Chen, W. L., Xu, L. L., Zhou, H. S., Bian, J. L., Yang, Y. R., Sun, H. P., Xu, X. L., & You, Q. D. (2016). NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA\/ROCK pathway signal transduction. Oncotarget, 7(45), 73593.","journal-title":"Oncotarget"},{"key":"872_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.biopha.2017.04.027","volume":"91","author":"S Kumari","year":"2017","unstructured":"Kumari, S., Badana, A. K., Mohan, G. M., ShailenderNaik, G., & Malla, R. (2017). Synergistic effects of coralyne and paclitaxel on cell migration and proliferation of breast cancer cells lines. Biomedicine & Pharmacotherapy, 91, 436\u2013445.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"872_CR38","first-page":"116","volume":"13","author":"Z Payandeh","year":"2021","unstructured":"Payandeh, Z., PirpourTazehkand, A., Mansoori, B., Khaze, V., Asadi, M., Baradaran, B., & Samadi, N. (2021). The impact of Nrf2 silencing on Nrf2-PD-L1 axis to overcome oxaliplatin resistance and migration in colon cancer cells. Avicenna Journal of Medical Biotechnology, 13(3), 116.","journal-title":"Avicenna Journal of Medical Biotechnology"},{"issue":"11","key":"872_CR39","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1002\/fsn3.1154","volume":"7","author":"XQ Zhang","year":"2019","unstructured":"Zhang, X. Q., Yao, C., Bian, W. H., Chen, X., Xue, J. X., Zhu, Z. Y., Ying, Y., Xu, Y. L., & Wang, C. (2019). Effects of astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K\/AKT\/mTOR signaling pathway. Food Science & Nutrition, 7(11), 3403\u20133413.","journal-title":"Food Science & Nutrition"},{"issue":"5","key":"872_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4196\/kjpp.2017.21.5.465","volume":"21","author":"F Kong","year":"2017","unstructured":"Kong, F., Zhang, R., Zhao, X., Zheng, G., Wang, Z., & Wang, P. (2017). Resveratrol raises in vitro anticancer effects of paclitaxel in NSCLC cell line A549 through COX-2 expression. The Korean Journal of Physiology & Pharmacology, 21(5), 465\u2013474.","journal-title":"The Korean Journal of Physiology & Pharmacology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00872-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00872-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00872-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:43:27Z","timestamp":1727300607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00872-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["872"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00872-2","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,23]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research protocol was approved by the Ethics Committee of Tabriz University of Medical Sciences, Iran (IR.TBZMED.VCR.REC.1400.329).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}